USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
NEURODX DEVELOPMENT, LLC
Address:
3333 Street Road
SUITE 210
Bensalem, PA
Phone:
N/A
URL:
N/A
EIN:
126360683
DUNS:
828682240
Number of Employees:
N/A
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $1,961,749.00 5
SBIR Phase II $3,983,300.00 2

Award List:

Micro-Pumper method for improving the specificity of CSF shunt patency testing

Award Year / Program / Phase:
2010 / SBIR / Phase I
Award Amount:
$143,737.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): This Phase 1 SBIR will develop a portable, non-invasive tool which will improve the diagnostic accuracy of kinetic shunt patency testing, including radionuclide studies or ShuntCheck tests, in pediatric hydrocephalus pa tients. This will improve clinical care for… More

ShuntCheck Clinical Validation and ShuntCheck-Micro-Pumper Assessment of CSF Shun

Award Year / Program / Phase:
2010 / SBIR / Phase I
Award Amount:
$699,992.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): The goal of this SBIR is to create the first comprehensive set of clinical tools and noninvasive methods for diagnosing cerebrospinal fluid (CSF) shunt obstruction and to validate them to convince clinicians of thei r clinical value. Hydrocephalus is a common… More

A Double-Blinded Comparison of the Accuracy of ShuntCheck, a Non-Invasive Device

Award Year / Program / Phase:
2011 / SBIR / Phase I
Award Amount:
$210,038.00
Agency:
HHS
Principal Investigator:
Marek Swoboda – 215-645-1280
Abstract:
DESCRIPTION (provided by applicant): This Phase 1 SBIR will develop a non-invasive alternative to radionuclide shunt patency testing for evaluating Normal Pressure Hydrocephalus (NPH) patients with suspected shunt malfunction. Hydrocephalus is a disorder of cerebrospinal fluid dynamics that is… More

Continuous Real Time CSF Shunt Flow Monitor ShuntCheck

Award Year / Program / Phase:
2011 / SBIR / Phase I
Award Amount:
$257,203.00
Agency:
HHS
Principal Investigator:
Marek Swoboda – 215-645-1280
Abstract:
DESCRIPTION (provided by applicant): This Phase 1 SBIR will develop Continuous Real Time (CRT) ShuntCheck, the first portable, non- invasive device for real time, continuous monitoring of flow in CSF shunts. This device will result in improved clinicalmanagement of hydrocephalus by providing a… More

Validation of ShuntCheck-Micro-Pumper, a non-invasive diagnostic procedure for de

Award Year / Program / Phase:
2011 / SBIR / Phase II
Award Amount:
$2,989,549.00
Agency:
HHS
Principal Investigator:
Marek Swoboda – 215-645-1280
Abstract:
DESCRIPTION (provided by applicant): This Phase 2 SBIR will provide and clinically validate the first portable, non-invasive diagnostic test for differentiating intermittently flowing patent shunts from occluded or partially occluded shunts - ShuntCheck- Micro-Pumper. This device will result in… More

Long Term Implantable ICP Monitor for Hydrocephalus Patients

Award Year / Program / Phase:
2012 / SBIR / Phase I
Award Amount:
$650,779.00
Agency:
HHS
Principal Investigator:
Marek Swoboda – 215-645-1280
Abstract:
DESCRIPTION (provided by applicant): This Phase I SBIR will develop ICPCheck, the first long term implantable, non-invasively readable intracranial pressure (ICP) monitor for hydrocephalus patients. This device will result in improved clinical management of hydrocephalus by providing a rapid and… More

Continuous Real Time CSF Shunt Flow Monitor ShuntCheck

Award Year / Program / Phase:
2013 / SBIR / Phase II
Award Amount:
$993,751.00
Agency:
HHS
Principal Investigator:
Marek Swoboda – 215-645-1280
Abstract:
DESCRIPTION (provided by applicant): This Phase II SBIR will develop Continuous Real Time (CRT) ShuntCheck, the first portable, non- invasive device for real time, continuous monitoring of changes in flow in CSF shunts. This device will result in improvedclinical management of hydrocephalus by… More